A combination of idelalisib and rituximab is an effective and safe treatment for patients with relapsed chronic lymphocytic leukemia, according to the results of a phase III clinical trial.
Browsing: Research
Northwestern has established a new Institute for Global Health that aims to improve health in middle- and lower-income countries around the world and deepens the medical school’s commitment to solving health problems worldwide.
Northwestern Medicine scientists have identified the critical role that a specific ion channel plays in the activity of brain cells called astrocytes.
A drug called regorafenib significantly improved progression-free survival in patients with metastatic osteosarcoma, according to a study published in the Journal of Clinical Oncology.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
An artificial intelligence system was able to detect malignant lung cancer nodules on CT scans as well as — or better — than expert radiologists, according to a new study.
Waiting to begin treatments for diabetic macular edema until patients experience vision loss resulted in similar outcomes compared to starting treatments prior to vision loss, according to a recent study published in JAMA.
Students in the Physician Assistant Program capped off their second year with presentations on clinical literature reviews.
A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
Vincent Chen, a fourth-year medical student, was the first author of a study that estimated the lifetime risk for hypertension under new blood pressure thresholds.